Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine 2020-10-16 05:35
Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42，an FXR Agonist 2020-10-12 08:30
Foresee Pharmaceuticals Announces NDA for CAMCEVI(TM) 42MG Accepted for Review by the FDA 2020-10-09 06:39
I-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency 2020-09-30 20:00
The 11th China (Taizhou) International Medical Expo ended successfully 2020-09-30 19:52
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand 2020-09-30 15:51
VolitionRx Limited Announces Virtual Capital Markets Day 2020 2020-09-29 20:00
GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program 2020-09-24 22:00
Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases 2020-09-24 08:00
ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital 2020-09-24 00:09
I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma 2020-09-21 20:00
PharmAbcine expands partnership with Samsung Biologics for PMC-403 2020-09-21 20:00
Preparation products of Yiling Pharma approved by FDA for launch in the US market 2020-09-19 19:14
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer 2020-09-18 04:05
Dr. Steven Yu Joins ChemPartner as Vice President of Regulated Bioanalysis 2020-09-17 23:01
Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc. 2020-09-17 22:00
Samsung Biologics signs development agreement with Panolos for solid tumor treatment 2020-09-17 08:43
Transcenta Successfully Scaled up the Continuous Perfusion Process and Completed GMP Manufacturing of a Novel Bispecific Antibody for Cancer Immunotherapy 2020-09-15 23:00
NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients 2020-09-11 20:55
Tottenham Acquisition I Limited Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Clene Nanomedicine, Inc. 2020-09-10 20:56
1 115 116 117 118 119 165